Hydrogen Peroxide-Triggered Conversion of Boronic Acid-Appended Insulin into Insulin and Its Application as a Glucose-Responsive Insulin Formulation

Mol Pharm. 2021 Nov 1;18(11):4224-4230. doi: 10.1021/acs.molpharmaceut.1c00760. Epub 2021 Oct 8.

Abstract

p-Boronophenylmethoxycarbonyl (BPmoc) is a protecting group for amines that is removable by treatment with hydrogen peroxide (H2O2). We prepared BPmoc-modified insulin (BPmoc-Ins) and subcutaneously injected the formulation into diabetic rats. The results demonstrated that BPmoc effectively sealed the blood glucose (Glc)-lowering effects of Ins. Conversely, coinjection of BPmoc-Ins and Glc oxidase (GOx) resulted in reduced blood Glc levels, indicating that Ins was generated from BPmoc-Ins through the following reactions: oxidation of endogenous Glc by GOx; production of H2O2 accompanied by Glc oxidation; removal of BPmoc residues by H2O2. These results show the potential of BPmoc-Ins for a Glc-responsive Ins release system.

Keywords: boronic acid; glucose-responsive release; hydrogen peroxide; hypoglycemia; insulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Blood Glucose / chemistry
  • Blood Glucose / drug effects*
  • Boronic Acids / chemistry
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Disease Models, Animal
  • Drug Liberation
  • Glucose Oxidase / metabolism
  • Humans
  • Hydrogen Peroxide / chemistry*
  • Hydrogen Peroxide / metabolism
  • Injections, Subcutaneous
  • Insulin, Regular, Human / administration & dosage*
  • Insulin, Regular, Human / chemistry
  • Insulin, Regular, Human / pharmacokinetics
  • Oxidation-Reduction
  • Rats

Substances

  • Blood Glucose
  • Boronic Acids
  • Delayed-Action Preparations
  • Insulin, Regular, Human
  • Hydrogen Peroxide
  • Glucose Oxidase